Financial Contrast: BrainsWay (NASDAQ:BWAY) and CVR Medical (OTCMKTS:CRRVF)

BrainsWay (NASDAQ:BWAY) and CVR Medical (OTCMKTS:CRRVF) are both small-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their analyst recommendations, dividends, valuation, risk, earnings, profitability and institutional ownership.

Insider and Institutional Ownership

30.1% of BrainsWay shares are owned by institutional investors. 19.0% of BrainsWay shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

Profitability

This table compares BrainsWay and CVR Medical’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
BrainsWay	3.88%	3.52%	2.26%
CVR Medical	N/A	N/A	N/A

Earnings & Valuation

This table compares BrainsWay and CVR Medical”s revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
BrainsWay	$38.63 million	4.08	-$4.20 million	$0.10	94.50
CVR Medical	N/A	N/A	-$1.82 million	N/A	N/A

CVR Medical has lower revenue, but higher earnings than BrainsWay.

Analyst Ratings

This is a summary of recent ratings and recommmendations for BrainsWay and CVR Medical, as reported by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
BrainsWay	0	0	3	0	3.00
CVR Medical	0	0	0	0	0.00

BrainsWay presently has a consensus target price of $13.17, suggesting a potential upside of 39.33%. Given BrainsWay’s stronger consensus rating and higher probable upside, research analysts clearly believe BrainsWay is more favorable than CVR Medical.

Summary

BrainsWay beats CVR Medical on 9 of the 10 factors compared between the two stocks.

About BrainsWay

BrainsWay Ltd. develops and sells noninvasive neurostimulation treatments for mental health disorders in the United States and internationally. It offers Deep Transcranial Magnetic Stimulation platform technology for the treatment of major depressive disorders, anxious depression, obsessive-compulsive disorders, smoking addiction, bipolar disorders, post traumatic stress disorders, schizophrenia, Alzheimer's disease, autism, chronic pain, multiple sclerosis, post stroke rehabilitation, and Parkinson's diseases. The company serves doctors, hospitals, and medical centers in the field of psychiatry. BrainsWay Ltd. was founded in 2003 and is headquartered in Jerusalem, Israel.

About CVR Medical

CVR Medical Corp., a healthcare company, engages in the research and development of subsonic, infrasonic, and low frequency sound wave analysis technology for the healthcare sector. The company provides carotid stenotic scan device, a diagnostic tool to detect and measure carotid arterial stenosis. It offers its products for patients, payors, and healthcare providers. CVR Medical Corp. was incorporated in 1980 and is headquartered in North Vancouver, Canada.